Cullen/Frost Bankers, Inc. Seagen Inc. Transaction History

Cullen/Frost Bankers, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$191.51 - $216.16 $215,640 - $243,396	1,126 Added 2.14%	53,658 $11.4 Million
Q2 2023 Aug 04, 2023	BUY	$187.64 - $206.25 $6,755 - $7,425	36 Added 0.07%	52,532 $10.1 Million
Q1 2023 May 05, 2023	SELL	$127.59 - $203.08 $119,296 - $189,879	-935 Reduced 1.75%	52,496 $10.6 Million
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $414,902 - $491,965	3,535 Added 7.08%	53,431 $6.87 Million
Q3 2022 Nov 07, 2022	BUY	$135.27 - $180.11 $149,743 - $199,381	1,107 Added 2.27%	49,896 $6.83 Million
Q2 2022 Aug 05, 2022	SELL	$108.81 - $179.33 $438,395 - $722,520	-4,029 Reduced 7.63%	48,789 $8.63 Million
Q1 2022 May 09, 2022	SELL	$119.61 - $157.85 $492,434 - $649,868	-4,117 Reduced 7.23%	52,818 $7.61 Million
Q4 2021 Feb 07, 2022	SELL	$142.57 - $190.86 $195,035 - $261,096	-1,368 Reduced 2.35%	56,935 $8.8 Million
Q3 2021 Nov 04, 2021	BUY	$142.45 - $169.82 $296,723 - $353,735	2,083 Added 3.71%	58,303 $9.9 Million
Q2 2021 Aug 05, 2021	BUY	$135.08 - $161.1 $315,817 - $376,651	2,338 Added 4.34%	56,220 $8.88 Million
Q1 2021 May 05, 2021	BUY	$137.51 - $190.8 $481,972 - $668,754	3,505 Added 6.96%	53,882 $7.48 Million
Q4 2020 Feb 08, 2021	BUY	$164.63 - $211.93 $8.29 Million - $10.7 Million	50,377 New	50,377 $8.82 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.